Rhythm Pharmaceuticals (RYTM) EVP Jennifer Lee Sells $8.9M in Stock

Jennifer Lee, Executive Vice President of Rhythm Pharmaceuticals (RYTM), sold $8.9 million worth of stock. This significant transaction raises potential concerns regarding insider selling which can impact investor confidence. The transaction amount indicates a high level of trading activity from an executive, which may have implications for the market perception of the company's stability. Investors will closely monitor such insider actions as they can offer insights into the company's future performance.